Startup India Government of India
D P Pharmaceutical Private Limited
D P Pharmaceutical Private Limited - pharma in Noida, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.81 Lakh
▼ 94% YoY
Net loss · FY 2025
₹14,531
Net margin -8%
EBITDA · FY 2025
-₹14,531
EBITDA margin -8%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹10,000
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About D P Pharmaceutical Private Limited
Data last updated:
D P Pharmaceutical Private Limited is a private limited company based in Noida, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74999UP2020PTC125344. Its GSTIN is 09AAHCD6030B1Z2 (Uttar Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10,000. It is led by directors Wasim and Aslam Khan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No – 8 Village Garhi Sector – 143 Noida, Uttar Pradesh, India – 201304.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.81 Lakh, a decline of 94% compared to the previous year. For the same year it recorded a net loss of ₹14,531 (net margin -8%) and EBITDA of -₹14,531 (EBITDA margin -8%). Revenue has declined at a compounded annual rate (CAGR) of 71% over three years and 20% over five years.
Company details
CIN U74999UP2020PTC125344
Registration Number 125344
Incorporation Date 06 January 2020
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Key People
Wasim Director Aslam Khan Director Recognitions & Rankings of D P Pharmaceutical
Contact details
D P Pharmaceutical Private Limited's registered office is in Noida, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No – 8 Village Garhi Sector – 143 Noida, Uttar Pradesh, India – 201304
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of D P Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
D P Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of D P Pharmaceutical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of D P Pharmaceutical Private Limited, buy the company report.
Financials of D P Pharmaceutical Private Limited
FY 2025 filings availableD P Pharmaceutical Private Limited reported revenue of ₹1.81 Lakh (down 94% YoY) for FY 2025.
Revenue · FY 2025
₹1.81 Lakh ▼ 94%
Net loss · FY 2025
₹14,531 margin -8%
EBITDA · FY 2025
-₹14,531 margin -8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 94%
3 years · compounded
▼ 71%
5 years · compounded
▼ 20%
EBITDA CAGR growth
1 year
▲ 86%
3 years · compounded
▼ 30%
5 years · compounded
▼ 23%
Revenue has declined at a compounded annual rate (CAGR) of 20% over five years, including a 94% fall in the latest year. EBITDA rose 86% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹14,531 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹14,531 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -8% | ||||
| Net Profit Margin | -8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of D P Pharmaceutical Private Limited, buy the company report.
Board of directors of D P Pharmaceutical Private Limited
D P Pharmaceutical has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Wasim | Director | 26 Sep 2022 | 4 Years 1 Months | Current |
| Aslam Khan | Director | 26 Sep 2022 | 4 Years 1 Months | Current |
Peer comparison
D P Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dinkar Tradeimpex Private Limited | ₹1.81 Lakh (FY 2024) | -17.0% | Patna, Bihar, India | |||
| Antil Agritech Private Limited | ₹1.81 Lakh (FY 2025) | 92.0% | Delhi, India | |||
| Blissfy Information Technologies Private Limited | ₹1.81 Lakh (FY 2017) | Gwalior, Madhya Pradesh, India | ||||
| Vaishanavi Merchandise Pvt Ltd | ₹1.81 Lakh (FY 2024) | 2.0% | Kolkata, West Bengal, India | |||
| Rising Automobiles Private Limited | ₹1.81 Lakh (FY 2025) | 59.0% | Gurgaon, Haryana, India | |||
| D P Pharmaceutical Private Limitedthis company | ₹1.81 Lakh (FY 2025) | -₹14,531 | -8% | -94.0% | Noida, Uttar Pradesh, India | |
| Eazy-Breezy Sales and Service Private Limited | ₹1.81 Lakh (FY 2021) | -90.0% | Pune, Maharashtra, India | |||
| Vrksa Lifespace Private Limited | ₹1.81 Lakh (FY 2017) | -14.0% | Chennai, Tamil Nadu, India | |||
| Fashion Velvets India Private Limited | ₹1.81 Lakh (FY 2024) | -4.0% | Kalyan, Maharashtra, India | |||
| Rizwan Handicrafts Private Limited | ₹1.81 Lakh (FY 2025) | -34.0% | Delhi, India | |||
| Sri Parvathi Hi-Tech Products Limited | ₹1.81 Lakh (FY 2025) | 5.0% | Tamil Nadu, India |
To see the full peer comparison of D P Pharmaceutical Private Limited, buy the company report.
Auditor
D P Pharmaceutical Private Limited is audited by V C & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V C & CO | FY 2021 | 016307N |
Shareholding
The shareholding of D P Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of D P Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving D P Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for D P Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
D P Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCD6030B1Z2 | Uttar Pradesh | Active | 22 Jan 2020 |
To see the full GST registrations and return filing status of D P Pharmaceutical Private Limited, buy the company report.
Recent activity
D P Pharmaceutical Private Limited has 5 board changes on record since 2020: 2 appointments and 3 cessations. The latest: Meena Aggarwal ceased to be Director on 01 Oct 2022.
AGM
D P Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
D P Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Ceased
Meena Aggarwal ceased to be Director.
Ceased
Rishabh Gupta ceased to be Director.
Appointed
Aslam Khan was appointed as Director.
Appointed
Wasim was appointed as Director.
Ceased
Priyambada Mishra ceased to be Director.
Incorporation
06 Jan 2020
D P Pharmaceutical Private Limited was registered on 06 Jan 2020 with Roc Kanpur & aged 6 years 9 months as per MCA records.
Frequently asked questions
D P Pharmaceutical is an active private limited company based in Noida, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 January 2020 (6+ years old) and is registered under CIN U74999UP2020PTC125344.
D P Pharmaceutical has 2 current directors:
- Wasim - Director
- Aslam Khan - Director
The latest financial statements of D P Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of D P Pharmaceutical is 09AAHCD6030B1Z2, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of D P Pharmaceutical is U74999UP2020PTC125344. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
D P Pharmaceutical was incorporated on 06 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of D P Pharmaceutical by revenue are Dinkar Tradeimpex Private Limited, Antil Agritech Private Limited, Blissfy Information Technologies Private Limited, Vaishanavi Merchandise Pvt Ltd, Rising Automobiles Private Limited and 5 more, all in the same principal business activity (retail trading).
Meena Aggarwal ceased to be Director on 01 Oct 2022. Rishabh Gupta ceased to be Director on 01 Oct 2022. Aslam Khan was appointed as Director on 26 Sep 2022. D P Pharmaceutical has 5 board changes on record in total.
Yes, D P Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of D P Pharmaceutical is at H.No – 8 Village Garhi Sector – 143 Noida, Uttar Pradesh, India – 201304.
D P Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages